Skip to main content
. Author manuscript; available in PMC: 2017 Aug 4.
Published in final edited form as: Clin Cancer Res. 2017 Mar 17;23(15):4233–4241. doi: 10.1158/1078-0432.CCR-16-1209

Table 2.

Summary of Patient Tumour Characteristics

Primary Tumours Lymph Nodes
Pt Primary
site
P vol
[cc]
R2*
[s-1]
Ktrans
[min-1]
MR1
Fluct.
Vol.
[%]
MR2
Fluct.
Vol.
[%]
LN
vol
[cc]
R2*
[s-1]
Ktrans
[min-1]
MR1
Fluct.
Vol.
[%]
MR2
Fluct.
Vol.
[%]
Outcome
1 Oropharynx 12 50 0.153 1 4 15 52 0.264 1 1 R
2 51 0.186 2 10
2 Oropharynx 32 54 0.079 NA NA 3 38 0.046 0 0 R
3 Supraglottis 27 54 0.135 NA NA 2 42 0.277 4 6 NR
4 Oropharynx 29 47 0.112 2 1 - - - - - R
5 Oropharynx 173 54 0.147 0 2 6 48 0.129 8 23 NR
2 44 0.102 14 8
6 Supraglottis 12 56 0.145 NA NA 15 43 0.215 3 1 NR
7 Oropharynx - - - - - 5 38 0.139 7 5 NR
8 Supraglottis - - - - - 10 35 0.242 2 8 R
15 41 0.346 1 4
9 Oropharynx - - - - - 17 45 0.060 1 2 R
10 Oropharynx 45 56 0.117 1 4 - - - - - R

Median 28 54 0.135 1 3 5 43 0.186 2 5

“-”: no primary / lymph node in the imaged volume, “NA”: data not available due to extensive motion, “R/NR” – responder / non-responder;